SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-298702
Filing Date
2020-11-20
Accepted
2020-11-20 07:31:01
Documents
12
Period of Report
2020-11-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d77388d8k.htm   iXBRL 8-K 24776
  Complete submission text file 0001193125-20-298702.txt   151408

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA sldb-20201118.xsd EX-101.SCH 3071
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE sldb-20201118_lab.xml EX-101.LAB 18889
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sldb-20201118_pre.xml EX-101.PRE 11861
5 EXTRACTED XBRL INSTANCE DOCUMENT d77388d8k_htm.xml XML 3480
Mailing Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139
Business Address 141 PORTLAND STREET, FIFTH FLOOR CAMBRIDGE MA 02139 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 201330469
SIC: 2836 Biological Products, (No Diagnostic Substances)